primary antibody Search Results


96
Bio-Rad primary antibody ly6b
Primary Antibody Ly6b, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/us11766423-423-14-18?v=Bio-Rad
Average 96 stars, based on 1 article reviews
primary antibody ly6b - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Bio-Rad polyclonal primary antibodies
Polyclonal Primary Antibodies, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/fahmy_shaimaa__2023__unveiling_the_role_of_spop_in_dna_damage_response_and_double_strand_break_repair_from_mechanistic_insights-431-67-77?v=Bio-Rad
Average 96 stars, based on 1 article reviews
polyclonal primary antibodies - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

85
Rockland Immunochemicals rabbit polyclonal
Rabbit Polyclonal, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pmc03190939-146-12-14?v=Rockland+Immunochemicals
Average 85 stars, based on 1 article reviews
rabbit polyclonal - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier

96
Bio-Rad hfabtm rhodamine anti actin primary abs 280
Hfabtm Rhodamine Anti Actin Primary Abs 280, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pmc12513643__ppat%2E1013560%2Es001-122-78-86?v=Bio-Rad
Average 96 stars, based on 1 article reviews
hfabtm rhodamine anti actin primary abs 280 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

86
Rockland Immunochemicals primary rabbit polyclonal antibodies
Primary Rabbit Polyclonal Antibodies, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pmc03129659-138-0-20?v=Rockland+Immunochemicals
Average 86 stars, based on 1 article reviews
primary rabbit polyclonal antibodies - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

92
Rockland Immunochemicals rabbit anti ha
Rabbit Anti Ha, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pmc11548748-180-31-35?v=Rockland+Immunochemicals
Average 92 stars, based on 1 article reviews
rabbit anti ha - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

95
Bio-Rad bio rad 12004167
Bio Rad 12004167, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/geldert_alisha_m__2021__engineering_measurement_tools_to_advance_quantitative_single_cell_biology_and_pathogen_inactivation-2855-11-11?v=Bio-Rad
Average 95 stars, based on 1 article reviews
bio rad 12004167 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

90
ProSci Incorporated myd88
FIGURE 2. IFN-1a treatment up-regulates TLR7 and its signaling pathway, while it down-regulates the expression of IL-1R and IL-1/. A, Three 106 DCs per condition derived from 10 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 2 h before RNA extraction. TLR7, <t>MyD88,</t> IRAK4, TRAF6, IL-1R1, IL-1, and IL-1 gene expression was measured by RT- PCR. The results are presented as relative gene expression normalized for the 18S RNA expression. B, Three 106 DCs per condition from 16 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 48 h. DCs were stained with PE-Cy-CD11c, allophycocyanin-CD1a mAb, and anti-IL-1R1 Ab, followed by FITC-conjugated secondary Ab, anti-TLR7 primary Ab, and FITC-conjugated secondary Ab. FITC-conjugated IgG isotype Ab was used as a control. The percentage of positive cells was determined in the CD1a-gated population. C, Three 106 DCs per condition derived from three RR MS patients were pretreated by IFN-1a for 24 h and then matured with LPS for 5 h before protein extraction. The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin were measured by Western blotting. The results present one of three similar experiments.
Myd88, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pm19265172-95-38-45?v=ProSci+Incorporated
Average 90 stars, based on 1 article reviews
myd88 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

96
Bio-Rad hfab rhodamine anti β tubulin
FIGURE 2. IFN-1a treatment up-regulates TLR7 and its signaling pathway, while it down-regulates the expression of IL-1R and IL-1/. A, Three 106 DCs per condition derived from 10 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 2 h before RNA extraction. TLR7, <t>MyD88,</t> IRAK4, TRAF6, IL-1R1, IL-1, and IL-1 gene expression was measured by RT- PCR. The results are presented as relative gene expression normalized for the 18S RNA expression. B, Three 106 DCs per condition from 16 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 48 h. DCs were stained with PE-Cy-CD11c, allophycocyanin-CD1a mAb, and anti-IL-1R1 Ab, followed by FITC-conjugated secondary Ab, anti-TLR7 primary Ab, and FITC-conjugated secondary Ab. FITC-conjugated IgG isotype Ab was used as a control. The percentage of positive cells was determined in the CD1a-gated population. C, Three 106 DCs per condition derived from three RR MS patients were pretreated by IFN-1a for 24 h and then matured with LPS for 5 h before protein extraction. The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin were measured by Western blotting. The results present one of three similar experiments.
Hfab Rhodamine Anti β Tubulin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pmc12774363-321-19-22?v=Bio-Rad
Average 96 stars, based on 1 article reviews
hfab rhodamine anti β tubulin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

92
Rockland Immunochemicals blocking solution
FIGURE 2. IFN-1a treatment up-regulates TLR7 and its signaling pathway, while it down-regulates the expression of IL-1R and IL-1/. A, Three 106 DCs per condition derived from 10 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 2 h before RNA extraction. TLR7, <t>MyD88,</t> IRAK4, TRAF6, IL-1R1, IL-1, and IL-1 gene expression was measured by RT- PCR. The results are presented as relative gene expression normalized for the 18S RNA expression. B, Three 106 DCs per condition from 16 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 48 h. DCs were stained with PE-Cy-CD11c, allophycocyanin-CD1a mAb, and anti-IL-1R1 Ab, followed by FITC-conjugated secondary Ab, anti-TLR7 primary Ab, and FITC-conjugated secondary Ab. FITC-conjugated IgG isotype Ab was used as a control. The percentage of positive cells was determined in the CD1a-gated population. C, Three 106 DCs per condition derived from three RR MS patients were pretreated by IFN-1a for 24 h and then matured with LPS for 5 h before protein extraction. The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin were measured by Western blotting. The results present one of three similar experiments.
Blocking Solution, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pm22331434-37-12-17?v=Rockland+Immunochemicals
Average 92 stars, based on 1 article reviews
blocking solution - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

93
Proteintech antibodies against vap 1
FIGURE 2. IFN-1a treatment up-regulates TLR7 and its signaling pathway, while it down-regulates the expression of IL-1R and IL-1/. A, Three 106 DCs per condition derived from 10 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 2 h before RNA extraction. TLR7, <t>MyD88,</t> IRAK4, TRAF6, IL-1R1, IL-1, and IL-1 gene expression was measured by RT- PCR. The results are presented as relative gene expression normalized for the 18S RNA expression. B, Three 106 DCs per condition from 16 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 48 h. DCs were stained with PE-Cy-CD11c, allophycocyanin-CD1a mAb, and anti-IL-1R1 Ab, followed by FITC-conjugated secondary Ab, anti-TLR7 primary Ab, and FITC-conjugated secondary Ab. FITC-conjugated IgG isotype Ab was used as a control. The percentage of positive cells was determined in the CD1a-gated population. C, Three 106 DCs per condition derived from three RR MS patients were pretreated by IFN-1a for 24 h and then matured with LPS for 5 h before protein extraction. The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin were measured by Western blotting. The results present one of three similar experiments.
Antibodies Against Vap 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pm36774389-90-10-14?v=Proteintech
Average 93 stars, based on 1 article reviews
antibodies against vap 1 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Boster Bio anti myd88
FIGURE 2. IFN-1a treatment up-regulates TLR7 and its signaling pathway, while it down-regulates the expression of IL-1R and IL-1/. A, Three 106 DCs per condition derived from 10 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 2 h before RNA extraction. TLR7, <t>MyD88,</t> IRAK4, TRAF6, IL-1R1, IL-1, and IL-1 gene expression was measured by RT- PCR. The results are presented as relative gene expression normalized for the 18S RNA expression. B, Three 106 DCs per condition from 16 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 48 h. DCs were stained with PE-Cy-CD11c, allophycocyanin-CD1a mAb, and anti-IL-1R1 Ab, followed by FITC-conjugated secondary Ab, anti-TLR7 primary Ab, and FITC-conjugated secondary Ab. FITC-conjugated IgG isotype Ab was used as a control. The percentage of positive cells was determined in the CD1a-gated population. C, Three 106 DCs per condition derived from three RR MS patients were pretreated by IFN-1a for 24 h and then matured with LPS for 5 h before protein extraction. The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin were measured by Western blotting. The results present one of three similar experiments.
Anti Myd88, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody/pmc05712092-73-39-41?v=Boster+Bio
Average 93 stars, based on 1 article reviews
anti myd88 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

Image Search Results


FIGURE 2. IFN-1a treatment up-regulates TLR7 and its signaling pathway, while it down-regulates the expression of IL-1R and IL-1/. A, Three 106 DCs per condition derived from 10 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 2 h before RNA extraction. TLR7, MyD88, IRAK4, TRAF6, IL-1R1, IL-1, and IL-1 gene expression was measured by RT- PCR. The results are presented as relative gene expression normalized for the 18S RNA expression. B, Three 106 DCs per condition from 16 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 48 h. DCs were stained with PE-Cy-CD11c, allophycocyanin-CD1a mAb, and anti-IL-1R1 Ab, followed by FITC-conjugated secondary Ab, anti-TLR7 primary Ab, and FITC-conjugated secondary Ab. FITC-conjugated IgG isotype Ab was used as a control. The percentage of positive cells was determined in the CD1a-gated population. C, Three 106 DCs per condition derived from three RR MS patients were pretreated by IFN-1a for 24 h and then matured with LPS for 5 h before protein extraction. The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin were measured by Western blotting. The results present one of three similar experiments.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.

doi: 10.4049/jimmunol.0802226

Figure Lengend Snippet: FIGURE 2. IFN-1a treatment up-regulates TLR7 and its signaling pathway, while it down-regulates the expression of IL-1R and IL-1/. A, Three 106 DCs per condition derived from 10 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 2 h before RNA extraction. TLR7, MyD88, IRAK4, TRAF6, IL-1R1, IL-1, and IL-1 gene expression was measured by RT- PCR. The results are presented as relative gene expression normalized for the 18S RNA expression. B, Three 106 DCs per condition from 16 RR MS patients were pretreated with IFN-1a for 24 h and then matured with LPS for 48 h. DCs were stained with PE-Cy-CD11c, allophycocyanin-CD1a mAb, and anti-IL-1R1 Ab, followed by FITC-conjugated secondary Ab, anti-TLR7 primary Ab, and FITC-conjugated secondary Ab. FITC-conjugated IgG isotype Ab was used as a control. The percentage of positive cells was determined in the CD1a-gated population. C, Three 106 DCs per condition derived from three RR MS patients were pretreated by IFN-1a for 24 h and then matured with LPS for 5 h before protein extraction. The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin were measured by Western blotting. The results present one of three similar experiments.

Article Snippet: Nonspecific binding was blocked for 1 h in the blocking buffer (10 mM Tris (pH 7.5), 150 mM NaCl, 2% fish gelatin, and 1% OVA in double-distilled water) and incubated overnight with rabbit anti-human Ab for TLR7 (Abcam), MyD88, TRAF6 (Santa Cruz Biotechnology), and IRAK4 (ProSci) and with mouse anti-human Ab for IL1R1 and -actin (Santa Cruz Biotechnology).

Techniques: Expressing, Derivative Assay, RNA Extraction, Gene Expression, Reverse Transcription Polymerase Chain Reaction, RNA Expression, Staining, Control, Protein Extraction, Western Blot

FIGURE 4. IFN-1a modifies MyD88/IRAK4/ TRAF6 signaling and cytokine production in DCs through its induction of TLR7 expression. Three 106/well DCs generated from six RR MS patients were plated in antibiotic-free medium. After a 24-h incubation at 37oC, the DCs were transfected with TLR7 siRNA or control siRNA. The siRNA-treated cells were harvested and cultured in serum-free me- dium in the absence or presence of IFN-1 for 24 h, followed by LPS maturation for 5 h before the pro- tein extraction, and for 48 h before the SN collec- tion. A, The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin was measured by Western blotting. The results present one of three similar experiments. B, The production of IL-1, TGF-1, IL-23/p19, and IL-27 was measured by ELISA. The results present six experiments per- formed in triplicate. Statistical analysis was per- formed using a repeated measures ANOVA. , p 0.05; , p 0.01; and , p 0.001.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.

doi: 10.4049/jimmunol.0802226

Figure Lengend Snippet: FIGURE 4. IFN-1a modifies MyD88/IRAK4/ TRAF6 signaling and cytokine production in DCs through its induction of TLR7 expression. Three 106/well DCs generated from six RR MS patients were plated in antibiotic-free medium. After a 24-h incubation at 37oC, the DCs were transfected with TLR7 siRNA or control siRNA. The siRNA-treated cells were harvested and cultured in serum-free me- dium in the absence or presence of IFN-1 for 24 h, followed by LPS maturation for 5 h before the pro- tein extraction, and for 48 h before the SN collec- tion. A, The expression of TLR7, MyD88, IRAK4, TRAF6, IL-1R1, and -actin was measured by Western blotting. The results present one of three similar experiments. B, The production of IL-1, TGF-1, IL-23/p19, and IL-27 was measured by ELISA. The results present six experiments per- formed in triplicate. Statistical analysis was per- formed using a repeated measures ANOVA. , p 0.05; , p 0.01; and , p 0.001.

Article Snippet: Nonspecific binding was blocked for 1 h in the blocking buffer (10 mM Tris (pH 7.5), 150 mM NaCl, 2% fish gelatin, and 1% OVA in double-distilled water) and incubated overnight with rabbit anti-human Ab for TLR7 (Abcam), MyD88, TRAF6 (Santa Cruz Biotechnology), and IRAK4 (ProSci) and with mouse anti-human Ab for IL1R1 and -actin (Santa Cruz Biotechnology).

Techniques: Expressing, Generated, Incubation, Transfection, Control, Cell Culture, Extraction, Western Blot, Enzyme-linked Immunosorbent Assay